Fthl17b, a member of the ferritin heavy chain-like family, plays a crucial role in cellular iron homeostasis. Predicted to possess ferric and ferrous iron binding activities, Fthl17b is implicated in the intracellular sequestering of iron ions, particularly in the cytoplasm during early conceptus development. The orthologous relationship to human FTHL17 highlights its evolutionary conservation and functional significance. Activation of Fthl17b involves a sophisticated network of chemical regulators. Trichostatin A, a histone deacetylase inhibitor, facilitates Fthl17b activation by enhancing chromatin accessibility. SB431542 indirectly influences Fthl17b through TGF-β receptor inhibition, altering downstream signaling and gene expression. Forskolin, a cAMP activator, up-regulates Fthl17b via PKA-mediated pathways, enhancing its transcriptional activity. LY294002, a PI3K inhibitor, indirectly promotes Fthl17b by modulating AKT/mTOR signaling.
JQ1, a BET bromodomain inhibitor, enhances Fthl17b expression through epigenetic regulation. ATRA, a retinoic acid agonist, activates Fthl17b by modulating RAR/RXR pathway dynamics. U0126, a MEK1/2 inhibitor, indirectly stimulates Fthl17b via MAPK pathway modulation. Resveratrol, a SIRT1 activator, promotes Fthl17b by influencing histone acetylation dynamics. Bortezomib, a proteasome inhibitor, indirectly promotes Fthl17b by stabilizing relevant regulators. Dasatinib, a Src kinase inhibitor, modulates downstream signaling cascades to indirectly activate Fthl17b expression. Rapamycin, an mTOR inhibitor, influences protein translation, indirectly promoting Fthl17b expression. Ionomycin, a calcium ionophore, activates Fthl17b through the Ca2+/NFAT pathway, facilitating transcriptional activation. In summary, Fthl17b activation is a finely tuned process influenced by a diverse array of chemical regulators, each impacting specific cellular pathways and processes. This orchestrated network ensures the proper functioning of Fthl17b in iron homeostasis during early conceptus development.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Histone deacetylase inhibitor, promoting Fthl17b by enhancing chromatin accessibility and transcription factor binding. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
TGF-β receptor inhibitor, indirectly activating Fthl17b by modulating TGF-β signaling, leading to altered gene expression. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
PI3K inhibitor, influencing AKT/mTOR pathway and indirectly promoting Fthl17b expression by modulating cellular signaling. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $231.00 $863.00 | 1 | |
BET bromodomain inhibitor, enhancing Fthl17b via epigenetic regulation, facilitating transcriptional activation. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid agonist, influencing RAR/RXR pathway and indirectly activating Fthl17b gene expression in a ligand-dependent manner. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
MEK1/2 inhibitor, modulating MAPK pathway and indirectly stimulating Fthl17b by influencing downstream effectors. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
SIRT1 activator, promoting Fthl17b expression by modulating histone acetylation and deacetylation dynamics. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Proteasome inhibitor, impacting protein degradation and indirectly promoting Fthl17b levels by stabilizing relevant regulators. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $70.00 $145.00 | 51 | |
Src kinase inhibitor, modulating downstream signaling cascades and indirectly activating Fthl17b expression. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
mTOR inhibitor, influencing protein translation and indirectly promoting Fthl17b expression by modulating cellular pathways. | ||||||